-The Telegraph The Centre today told the Supreme Court that no prosecution could be launched against armed forces fighting “counter-insurgency” and sought four months to decide whether to grant sanction to prosecute officers over a 12-year-old alleged fake encounter in Kashmir. The Armed Forces (Special Powers) Act, invoked in “disturbed areas”, specifically mandates prior sanction before any prosecution can begin, the government told the court while replying to a notice on the...

The CBI is set to chargesheet policemen and government officials for the Nandigram firing once it receives the Bengal government’s sanction for prosecution. “We are preparing the chargesheet,” said a senior CBI official, claiming the agency had an airtight case. He did not reveal the identities of those who would be chargesheeted. “Next week, we will write to the Mamata Banerjee government seeking sanction for prosecution against the policemen, police officers and...

The Centre on Monday revised the wage rate under the Mahatma Gandhi National Rural Employment Guarantee Act and has decided to amend the Act to remove the existing disparity in minimum wage, even as the matter is scheduled to come up before the Supreme Court on April 9. The revision in the wage rate indexed to the Consumer Price Index for Agricultural Labour (CPIAL) will come into effect on April 1...

The proposed amendments to marriage laws lack the detail to guarantee women their full due   The cabinet’s decision to clear a bill providing for amendment to marriage laws has evoked mixed reactions within women’s organisations. While the introduction of the notion of matrimonial property within Indian family laws is a welcome move, the manner in which it is being done seems hasty and without due consideration of its implementability. There is...

-Economic and Political Weekly The compulsory licence for Nexavar is only the beginning of a new battle over drug prices. The grant of a compulsory licence (CL) to Natco Pharma, a relatively small Indian pharmaceutical company, to manufacture and sell the cancer drug sorafenib (Nexavar) has been rightly hailed as a major step forward for public health and the wider availability of life saving medicines.   The German pharmaceutical company Bayer holds the patent...